Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises KEYTO Group in connection with the acquisition of Enspecta
Mandate

Vinge advises KEYTO Group in connection with the acquisition of Enspecta

July 01, 2025 M&A IT, Telecommunications and Outsourcing Data protection and processing of personal data Insurance Law Employment and Benefits Commercial Agreements Intellectual Property

KEYTO Group continues its growth journey by strengthening its offering in Sweden as Enspecta joins the group. This strategic addition marks KEYTO’s entry into a new service vertical focused on home inspection, assessment and optimisation - and reinforces the ambition of a leading, tech-enabled one-stop destination for home-related services. 

Vinge's team mainly consisted of Jonas Bergström, Gustav Wahlberg and Ian Linde (M&A), Carla Håkansson and Gabriel Pålsson (Commercial Agreements), William Karo Persson and Ida Pettersson (Employment), Melinda Oldenburg (IP), Nicklas Thorgenzon and Sara Link (IT and GDPR), Olivia Carlsten and Josef Jatta Kölin (Insurance) and Caroline Löv (Transaction Support Coordinator). 

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026